Cardiac Abnormalities in Primary Hyperoxaluria
Farouk Mookadam(University of Arizona), Dawn S. Milliner(Mayo Clinic), Panupong Jiamsripong(Mayo Clinic in Arizona), John C. Lieske(Mayo Clinic), Travis Smith(Lake Erie College of Osteopathic Medicine), Carla G. Monico(Mayo Clinic in Arizona)
Cited by 79
Related Papers
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
The primary hyperoxalurias
|Kidney International|2009|373
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
|Kidney International|2013|350
Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stains
|Kidney International|2020|194
An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome
|The American Journal of Human Genetics|2018|184